Answers are grounded in this paper and cite their sources.
This cross-sectional study evaluates the association of generic competition and changes in product coverage and cost-sharing by using Medicare data and estimated out-of-pocket costs for the oral specialty drug abiraterone.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: